PROFUND ADVISORS LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,456,817
-0.0%
151,279
+10.4%
0.08%
+3.8%
Q2 2023$1,457,467
+14.0%
136,980
+12.7%
0.08%
-1.3%
Q1 2023$1,278,127
+461.1%
121,495
+560.8%
0.08%
+426.7%
Q4 2022$227,803
+20.5%
18,386
+1.0%
0.02%
+7.1%
Q3 2022$189,000
-23.8%
18,205
-15.4%
0.01%
-12.5%
Q2 2022$248,000
+38.5%
21,527
+50.9%
0.02%
+100.0%
Q1 2022$179,000
+0.6%
14,266
-6.3%
0.01%
+33.3%
Q4 2021$178,000
-6.3%
15,232
+4.6%
0.01%0.0%
Q3 2021$190,000
-8.7%
14,569
-9.8%
0.01%
-14.3%
Q2 2021$208,000
+20.9%
16,154
+5.0%
0.01%0.0%
Q1 2021$172,000
+4.2%
15,392
+6.4%
0.01%0.0%
Q4 2020$165,000
+34.1%
14,464
+5.4%
0.01%
+16.7%
Q3 2020$123,000
-17.4%
13,729
-5.0%
0.01%
-25.0%
Q2 2020$149,000
+9.6%
14,452
+6.9%
0.01%
-20.0%
Q1 2020$136,000
-34.3%
13,519
-13.1%
0.01%
+11.1%
Q4 2019$207,000
+88.2%
15,558
+21.7%
0.01%
+50.0%
Q3 2019$110,000
-30.8%
12,781
-12.1%
0.01%
-25.0%
Q2 2019$159,000
-16.3%
14,537
+3.8%
0.01%
-11.1%
Q1 2019$190,000
-20.2%
14,006
-39.0%
0.01%
-40.0%
Q4 2018$238,000
-51.6%
22,960
-13.9%
0.02%
-21.1%
Q3 2018$492,00026,6660.02%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,520,000$19,562,00018.54%
Sarissa Capital Management LP 16,390,000$210,939,00016.77%
Healthcare Value Capital, LLC 200,000$2,574,0005.13%
Camber Capital Management LP 7,500,000$96,525,0003.25%
13D Management LLC 650,455$8,371,0002.88%
BRIDGER MANAGEMENT, LLC 2,035,114$26,192,0002.44%
Brown Capital Management 18,484,759$237,899,0001.80%
Healthcare Value Capital, LLC 50,000$644,0001.28%
Zebra Capital Management LLC 53,359$687,0000.80%
PRICE MICHAEL F 520,000$6,692,0000.74%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders